These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25251373)

  • 1. Evolving therapeutic strategies to improve nonsteroidal anti-inflammatory drug safety.
    McCarberg BH; Cryer B
    Am J Ther; 2015; 22(6):e167-78. PubMed ID: 25251373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
    Fiorucci S; Santucci L; Distrutti E
    Dig Liver Dis; 2007 Dec; 39(12):1043-51. PubMed ID: 17997373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What's new in NSAID pharmacotherapy: oral agents to injectables.
    Atkinson TJ; Fudin J; Jahn HL; Kubotera N; Rennick AL; Rhorer M
    Pain Med; 2013 Dec; 14 Suppl 1():S11-7. PubMed ID: 24373105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COXIBs, CINODs and H₂S-releasing NSAIDs: current perspectives in the development of safer non steroidal anti-inflammatory drugs.
    Fiorucci S; Distrutti E
    Curr Med Chem; 2011; 18(23):3494-505. PubMed ID: 21756233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal safety of novel nonsteroidal antiinflammatory drugs: selective COX-2 inhibitors and beyond.
    Coruzzi G; Venturi N; Spaggiari S
    Acta Biomed; 2007 Aug; 78(2):96-110. PubMed ID: 17933277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NSAID-induced gastrointestinal damage and the design of GI-sparing NSAIDs.
    Wallace JL; Vong L
    Curr Opin Investig Drugs; 2008 Nov; 9(11):1151-6. PubMed ID: 18951293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs.
    Targownik LE; Metge CJ; Leung S; Chateau DG
    Gastroenterology; 2008 Apr; 134(4):937-44. PubMed ID: 18294634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen sulfide-based therapies: focus on H2S releasing NSAIDs.
    Fiorucci S; Santucci L
    Inflamm Allergy Drug Targets; 2011 Apr; 10(2):133-40. PubMed ID: 21275896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors.
    Laine L
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):25-32. PubMed ID: 12528071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Trends in nonsteroidal anti-inflammatory drug development and application].
    Miedzybrodzki R
    Postepy Hig Med Dosw (Online); 2004; 58():438-48. PubMed ID: 15577751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety.
    Pereira-Leite C; Nunes C; Jamal SK; Cuccovia IM; Reis S
    Med Res Rev; 2017 Jul; 37(4):802-859. PubMed ID: 28005273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
    Hochberg MC
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):4-14. PubMed ID: 12528069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NSAIDs for musculoskeletal pain management:current perspectives and novel strategies to improve safety.
    Atchison JW; Herndon CM; Rusie E
    J Manag Care Pharm; 2013; 19(9 Suppl A):S3-19. PubMed ID: 24261788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and emerging treatments for mild/moderate acute ambulatory pain.
    Weaver AL
    Am J Ther; 2008; 15 Suppl 10():S12-6. PubMed ID: 19127123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current approaches to prevent NSAID-induced gastropathy--COX selectivity and beyond.
    Becker JC; Domschke W; Pohle T
    Br J Clin Pharmacol; 2004 Dec; 58(6):587-600. PubMed ID: 15563357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoarthritis therapy--are there still unmet needs?
    Laufer S
    Rheumatology (Oxford); 2004 Feb; 43 Suppl 1():i9-15. PubMed ID: 14752170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
    Brzozowski T; Konturek PC; Pajdo R; Ptak-Belowska A; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Brzozowski B; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():89-102. PubMed ID: 18812631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in the response to non-steroidal anti-inflammatory drugs: mechanisms and perspectives.
    Bruno A; Tacconelli S; Patrignani P
    Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):56-63. PubMed ID: 23953622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsteroidal anti-inflammatory drugs exposure and the central nervous system.
    Auriel E; Regev K; Korczyn AD
    Handb Clin Neurol; 2014; 119():577-84. PubMed ID: 24365321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.